These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33252190)

  • 1. GRIN database: A unified and manually curated repertoire of GRIN variants.
    García-Recio A; Santos-Gómez A; Soto D; Julia-Palacios N; García-Cazorla À; Altafaj X; Olivella M
    Hum Mutat; 2021 Jan; 42(1):8-18. PubMed ID: 33252190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of homologous GluN subunits variants accelerates
    Santos-Gómez A; García-Recio A; Miguez-Cabello F; Soto D; Altafaj X; Olivella M
    Front Cell Neurosci; 2022; 16():998719. PubMed ID: 36619673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function.
    Santos-Gómez A; Miguez-Cabello F; García-Recio A; Locubiche-Serra S; García-Díaz R; Soto-Insuga V; Guerrero-López R; Juliá-Palacios N; Ciruela F; García-Cazorla À; Soto D; Olivella M; Altafaj X
    Hum Mol Genet; 2021 Feb; 29(24):3859-3871. PubMed ID: 33043365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
    Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
    Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradigmatic De Novo
    Santos-Gómez A; Miguez-Cabello F; Juliá-Palacios N; García-Navas D; Soto-Insuga V; García-Peñas JJ; Fuentes P; Ibáñez-Micó S; Cuesta L; Cancho R; Andreo-Lillo P; Gutiérrez-Aguilar G; Alonso-Luengo O; Málaga I; Hedrera-Fernández A; García-Cazorla À; Soto D; Olivella M; Altafaj X
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
    Tang W; Liu D; Traynelis SF; Yuan H
    Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor.
    Xu Y; Song R; Perszyk RE; Chen W; Kim S; Park KL; Allen JP; Nocilla KA; Zhang J; XiangWei W; Tankovic A; McDaniels ED; Sheikh R; Mizu RK; Karamchandani MM; Hu C; Kusumoto H; Pecha J; Cappuccio G; Gaitanis J; Sullivan J; Shashi V; Petrovski S; Jauss RT; Lee HK; Bozarth X; Lynch DR; Helbig I; Pierson TM; Boerkoel CF; Myers SJ; Lemke JR; Benke TA; Yuan H; Traynelis SF
    Cell Mol Life Sci; 2024 Mar; 81(1):153. PubMed ID: 38538865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology.
    Korinek M; Candelas Serra M; Abdel Rahman F; Dobrovolski M; Kuchtiak V; Abramova V; Fili K; Tomovic E; Hrcka Krausova B; Krusek J; Cerny J; Vyklicky L; Balik A; Smejkalova T
    Physiol Res; 2024 May; 73(Suppl 1):S413-S434. PubMed ID: 38836461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of missense variants in the N-methyl-d-aspartate receptor GRIN gene family as gain- or loss-of-function.
    Myers SJ; Yuan H; Perszyk RE; Zhang J; Kim S; Nocilla KA; Allen JP; Bain JM; Lemke JR; Lal D; Benke TA; Traynelis SF
    Hum Mol Genet; 2023 Sep; 32(19):2857-2871. PubMed ID: 37369021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct roles of
    Myers SJ; Yuan H; Kang JQ; Tan FCK; Traynelis SF; Low CM
    F1000Res; 2019; 8():. PubMed ID: 31807283
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    XiangWei W; Jiang Y; Yuan H
    Curr Opin Physiol; 2018 Apr; 2():27-35. PubMed ID: 29756080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions.
    Tang W; Beckley JT; Zhang J; Song R; Xu Y; Kim S; Quirk MC; Robichaud AJ; Diaz ES; Myers SJ; Doherty JJ; Ackley MA; Traynelis SF; Yuan H
    Cell Mol Life Sci; 2023 Jan; 80(2):42. PubMed ID: 36645496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurodevelopmental disorders associated with variants of GRIN gene family].
    Jiang X; Dong X; Zhou W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jul; 39(7):783-787. PubMed ID: 35810443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and therapeutic significance of genetic variation in the GRIN gene family encoding NMDARs.
    Benke TA; Park K; Krey I; Camp CR; Song R; Ramsey AJ; Yuan H; Traynelis SF; Lemke J
    Neuropharmacology; 2021 Nov; 199():108805. PubMed ID: 34560056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential responses of disease-related GRIN variants located in pore-forming M2 domain of N-methyl-D-aspartate receptor to FDA-approved inhibitors.
    Song R; Zhang J; Perszyk RE; Camp CR; Tang W; Kannan V; Li J; Xu Y; Chen J; Li Y; Liang SH; Traynelis SF; Yuan H
    J Neurochem; 2024 Dec; 168(12):3936-3949. PubMed ID: 37649269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnane-based steroids are novel positive NMDA receptor modulators that may compensate for the effect of loss-of-function disease-associated GRIN mutations.
    Kysilov B; Hrcka Krausova B; Vyklicky V; Smejkalova T; Korinek M; Horak M; Chodounska H; Kudova E; Cerny J; Vyklicky L
    Br J Pharmacol; 2022 Aug; 179(15):3970-3990. PubMed ID: 35318645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
    Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
    J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Targeted Mice with Conditional Knock-In (-Out) of NMDAR Mutations.
    Sprengel R; Eltokhi A; Single FN
    Methods Mol Biol; 2017; 1677():201-230. PubMed ID: 28986875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Serine Treatment is Associated with Improvements in Behavior, EEG, and Seizure Frequency in Individuals with GRIN-Related Disorders Due to Null Variants.
    Krey I; von Spiczak S; Johannesen KM; Hikel C; Kurlemann G; Muhle H; Beysen D; Dietel T; Møller RS; Lemke JR; Syrbe S
    Neurotherapeutics; 2022 Jan; 19(1):334-341. PubMed ID: 34997442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel opening.
    Xie L; McDaniel MJ; Perszyk RE; Kim S; Cappuccio G; Shapiro KA; Muñoz-Cabello B; Sanchez-Lara PA; Grand K; Zhang J; Nocilla KA; Sheikh R; Armengol L; Romano R; Pierson TM; Yuan H; Myers SJ; Traynelis SF
    Cell Mol Life Sci; 2023 Mar; 80(4):110. PubMed ID: 37000222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.